What are the Current Problems and Major Challenges of the Care for Periodontal Health
Journal Title: Public Health Open Access - Year 2018, Vol 2, Issue 1
Abstract
The worldwide prevalence of periodontal diseases is 5-20% in the adult population. Periodontitis is the second largest oral health problem, affecting 10-15% of the world s population. The most severe forms of periodontal diseases significantly affect adults, which are 35-44 years of age with prevalence of 19%. The recent systematic reviews of the Global Burden of Disease Study (GBD) in 2010 that use a large dataset of 291,170 individuals (aged 15–99) from 37 different countries show that severe periodontitis is the sixth most prevalent among all 291 diseases and conditions, affecting 11,2% of the global population, or 743 million people. According to some authors severe periodontitis has significant socioeconomic impacts and it indeed accounts for a surprisingly high global cost (US$54 billion yearly) of lost productivity. According to the American Academy of Period ontology, chronic periodontitis is more prevalent among adults; the amount of bone loss is compatible with local characteristics; subgingival calculus is a common finding; and the disease usually has slow to moderate progression. Notably, chronic periodontitis is the major cause of severe tooth loss and edentulism in the adult population worldwide.
Authors and Affiliations
Musurlieva N and Stoykova M
Keywords
Related Articles
- EP ID EP755496
- DOI 10.23880/phoa-16000127
- Views 2
- Downloads 0
Sexual Experience and Contraceptive Use among Unmarried Adolescent University Students in Mandalay, Myanmar
Increase in proportion of sexually active adolescents and insufficient use of effective contraceptive methods contributed to an increase in unintended teenage pregnancy, abortion and STI among adolescents in Myanmar. The...
Effects of Stakeholder’s Management and Engagement on the Success of Fixed Dose Combination (FDC) Tenofovir/Lamivudine/Dolutegravir (TLD) Introduction and Transition: Nigeria Experience
Introduction/Objectives: Managing the expectations and interest of the stakeholders’ is key to the success of new drug/regimen introduction and transition. This is because stakeholders are often heterogeneous and diverse...
Global and Regional Analysis Regarding BCG Immunization and Severity of Covid-19
The Role of BCG tuberculosis vaccine in the severity of Covid-19 is analyzed and it is observed that a number of cases supporting the possible correlation between the administrations of BCG vaccine in the population obse...
COVID-19 Pandemic in Turkey and Kerala, India: Some Observations
There is still lack of clarity regarding the effectiveness of various control measures in containing the COVID-19 pandemic. The experiences from different countries or contexts are diverse. For instance in Kerala state o...
Status Report on HIV Drug Treatment Transition from Tenofovir/Lamivudine/Efavirenz (TLE 600mg) to Tenofovir/Lamivudine/Dolutegravir (TLD) in Malawi
The Malawi Antiretroviral therapy (ART) program has over 740,000 patients on ART by end of September, 2017. This represents 71% of the estimated 1,036,000 HIV positive population [1]. In December 2017, the Ministry of He...